AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$PACS

Murray Jason Hulse sold $2.2M of PACS

Murray Jason Hulse (Co-Founder, CEO & Chairman) sold 45,707 shares of PACS Group, Inc. (PACS) at an average of $47.64 ($47.57–$47.65, $2.18M total) across 3 trades over 2026-10-19 to 2026-10-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Murray Jason Hulse
Published Oct 21, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PACS
Bearish
medium confidence
Mentioned
$PACS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSBearishLow
01

Why it matters

The disclosed sale may prompt short‑term selling pressure, but the overall effect is likely limited.

02

Market read

Insider sell of $2.2M is a modest but noteworthy event for traders monitoring PACS.

03

What to watch

The 10b5‑1 plan may have been set months ago, reducing the informational value of the trade.

Relevance 5/10Novelty 4/10Timing: post‑market today

Background

Form 4 filings disclose insider transactions; a sale by a founder/CEO often draws trader attention.

Company-level read

Ticker impact

$PACSBearishMedium confidence
Context

CEO Murray Hulse sold 45,707 shares for $2.18M via a 10b5‑1 plan, reducing his stake to 54.27M shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A $2.2M open‑market sale by the founder/CEO is material enough to attract attention, but the size is modest relative to total shares outstanding.

Market effects

Sector

Minimal impact on the broader health‑care services sector.

Regional

Limited to U.S. investors tracking insider activity.

Global

Low

Counterpoint

What could challenge this read

The sale could be routine under a pre‑arranged plan, not indicative of future performance.

Key entities

  • company
    PACS Group, Inc.

    U.S. listed health‑care services provider (NASDAQ: PACS).

  • person
    Murray Jason Hulse

    Co‑Founder, CEO & Chairman of PACS.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PACS insider trading history →

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

finance.yahoo.com
$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

finance.yahoo.com
$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.

investing.com